Speaking at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce, Victoria Metaxa, MD, PhD, of King’s College Hospital NHS Foundation Trust, London, UK, discusses some of the potential ethical issues that are associated with ‘miracle cures’ such as CAR-T which display results with huge potential. Dr Metaxa notes the need for discussion surrounding the treatment of end-stage patients and the costs of a treatment such as this.